INM · CIK 0001728328 · operating
InMed Pharmaceuticals Inc. (INM) is a pharmaceutical preparations company incorporated in British Columbia, Canada, listed on the Nasdaq. With a market capitalization of $3 million, InMed Pharmaceuticals Inc. is a micro-cap company. The stock currently trades at $0.83, down 2.36% today, with a 52-week range of $0.85–$7.98.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-8.36 | $-8.36 | -727.7% | |
| 2024 | $-1.01 | $-1.01 | +68.9% | |
| 2023 | $-3.25 | $-3.25 | +90.2% | |
| 2022 | $-33.17 | $-33.17 | — | |
| 2021 | — | — | — |